When periods start going haywire in the mid-to-late forties, the silence around what's actually normal is striking. Women either convince themselves it's all fine and ignore things that should be checked, or they spiral into fear about cancer every time a cycle runs long. The truth sits somewhere much more navigable than either extreme — and knowing where the real lines are changes everything.
Learn more about Rose →Menstrual irregularity can begin years — sometimes a full decade — before the final period, typically starting in the mid-to-late forties but occasionally in the early forties for some women. This early phase, known as the menopausal transition, is characterized by fluctuating estrogen levels driven by declining ovarian follicle reserves, which disrupts the predictable hormonal rhythm that regulates cycle length. Waiting for periods to become dramatically irregular before considering perimenopause means many women miss the transition entirely or attribute symptoms to stress, thyroid issues, or other causes without investigating further.
In perimenopause, cycles that stretch to 35, 40, or even 60 days are physiologically expected and reflect the increasingly erratic timing of ovulation — or its occasional absence altogether, known as anovulation. During anovulatory cycles, progesterone is not produced in sufficient quantities, which allows estrogen to continue building the uterine lining for longer before it eventually sheds. A longer cycle in a woman in her late forties with no other concerning features is far more likely to reflect normal hormonal flux than pathology.
While heavy periods are extremely common in perimenopause — driven by anovulatory cycles that allow prolonged estrogen stimulation of the endometrium without the counterbalancing effect of progesterone — this does not mean all heavy bleeding is automatically benign. Endometrial hyperplasia, uterine polyps, fibroids, and in rarer cases endometrial cancer can all present as heavy perimenopausal bleeding and are clinically indistinguishable from hormonal causes without investigation. Any bleeding that soaks through a pad or tampon every hour for two or more consecutive hours, or that causes dizziness or fatigue, warrants prompt medical review.
Intermenstrual spotting is common in perimenopause and is frequently caused by the same estrogen fluctuations that disrupt cycle regularity — a mid-cycle estrogen dip can trigger light spotting as the uterine lining briefly destabilizes. However, the nuance here is important: spotting that is new, persistent, postcoital, or occurs in a woman who has gone 12 months without a period (and is therefore officially postmenopausal) does require investigation. Context determines urgency — not every spot of blood is sinister, but not every instance should be dismissed either.
Fertility does decline significantly in the mid-forties, but ovulation continues to occur unpredictably throughout perimenopause, meaning pregnancy remains biologically possible until the final menstrual period has been confirmed. A woman in perimenopause who misses a period and assumes it is simply part of the transition may delay a pregnancy test, which matters both for family planning decisions and for the different medical considerations that accompany pregnancy at this stage of life. Contraception is still clinically recommended for women who do not wish to conceive until they have been period-free for 12 consecutive months.
The perimenopausal transition is not a linear process — estrogen levels fluctuate unpredictably, which means periods can temporarily settle into a more regular pattern for several months before becoming erratic again. This oscillation is a documented feature of the hormonal landscape of perimenopause and does not signal that the transition has reversed or concluded. A woman who experiences a few regular cycles after a period of irregularity should not assume her hormones have stabilized, particularly if other symptoms like hot flashes or sleep disruption persist.
Transvaginal ultrasound is a useful first-line tool for assessing endometrial thickness and identifying structural abnormalities like polyps or fibroids, but it has limitations — it cannot confirm or exclude endometrial hyperplasia or cancer on its own. In premenopausal and perimenopausal women, endometrial thickness varies substantially across the cycle, making thickness measurements less diagnostically straightforward than in postmenopausal women. When there is clinical concern, endometrial sampling (biopsy) or hysteroscopy provides the histological information that imaging alone cannot deliver.
Any bleeding that occurs after 12 consecutive months without a period is classified as postmenopausal bleeding and is an established clinical red flag that requires investigation to exclude endometrial cancer, regardless of how light or brief it is. While most cases of postmenopausal bleeding have benign causes — atrophic vaginitis and endometrial polyps are the most common — approximately 10% are attributable to endometrial cancer, which has an excellent prognosis when caught early. This is one situation where the myth of reassurance carries genuine risk, and no amount of self-reassurance substitutes for a proper evaluation.
Women using hormonal contraception — particularly combined oral contraceptives or hormonal IUDs — often find it difficult to identify perimenopausal changes because the hormones mask natural cycle patterns and can suppress or alter bleeding entirely. This is a real and legitimate challenge, not a myth to dismiss, but the misconception lies in the assumption that this means nothing can be known: symptoms like hot flashes, mood shifts, and sleep disruption can still emerge despite contraceptive use and provide useful clinical information. For women on the pill in their late forties, some clinicians recommend periodic FSH testing during the pill-free interval to get a rough indication of hormonal status, though this has limitations.
Cervical screening (smear tests or Pap tests) checks for cervical cell abnormalities and HPV — it does not assess the uterine lining or provide any information about endometrial health. These are entirely different tests investigating entirely different tissues, and a recent normal smear result offers no reassurance about the endometrium. Women who receive normal smear results sometimes delay reporting heavy or irregular bleeding because they believe they have recently been 'checked,' which can create a dangerous gap between symptoms and appropriate investigation.
Healthcare providers vary significantly in their familiarity with the breadth of normal perimenopausal bleeding patterns, and dismissal of symptoms as 'just perimenopause' without examination or investigation is unfortunately not uncommon, particularly in primary care settings where appointment time is limited. Women who are repeatedly reassured but continue to experience symptoms that concern them — particularly very heavy bleeding, bleeding with clots, or any postmenopausal bleeding — have every right to request a referral to a gynecologist for further evaluation. Trusting one's own sense that something is not right, and being persistent about it, has been the mechanism behind many early diagnoses.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.